NDC product
URIMAR-T CAPS
NDC 28595-224 · Allegis Pharmaceuticals, LLC
Key facts
| Product NDC | 28595-224 |
|---|---|
| Proprietary name | URIMAR-T CAPS |
| Nonproprietary name | methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate |
| Substances | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, HYOSCYAMINE SULFATE |
| Dosage form | CAPSULE |
| Route | ORAL |
| Labeler | Allegis Pharmaceuticals, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC] |
| Marketing start | Jun 28, 2023 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: